State Street SPDR S&P Biotech ETF

The current price of XBI is $136.69 USD — it has increased by +0.51% in the past 24 hours.

The monthly change is a +4.81% rise. Over the last year, XBI has showed a +68.25% increase.

XBI assets under management is $8.3B USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.

XBI expense ratio is 0.35%. It's an important metric for helping understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.

XBI shares are issued by SPDR.

Yes, XBI pays a dividend yield of 0.32%.

Investors in Latin America can buy foreign ETFs through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the fund.

Many investors in Latin America buy international ETFs like XBI to protect their purchasing power. Because XBI is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your portfolio remains protected from local inflation.

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.